Table 2.
Number of Patients in the Matched Treatment and Control Arms Who Experienced Primary (Hospital Discharge) or Secondary (Inpatient Mortality) Outcomes
| Outcome Measure | Control | CCP-Treated | Hazard Ratio (95% CI) | P |
|---|---|---|---|---|
| Propensity score–matched cohorts | ||||
| n | 188 | 188 | ||
| Hospital discharge | 165 | 161 | .67 (.54, .85) | .00053 |
| Inpatient mortality | 23 | 27 | .81 (.46, 1.43) | .47 |
| CCP infusion within 7 days of admission | ||||
| n | 179 | 179 | ||
| Hospital Discharge | 158 | 155 | .84 (.67, 1.04) | .11 |
| Inpatient Mortality | 21 | 24 | 1.08 (.59, 1.97) | .81 |
| CCP infusion within 3 days of admission | ||||
| n | 161 | 161 | ||
| Hospital discharge | 139 | 141 | .77 (.42, 1.42) | .41 |
| Inpatient mortality | 22 | 20 | .83 (.66, 1.06) | .13 |
Abbreviations: CCP, COVID-19 convalescent plasma; CI, confidence interval; COVID-19, coronavirus disease 2019.